Navigating the stock market can feel like sailing through a storm. Analyst ratings offer valuable insights, acting as a compass to guide investors. Here's a look at recent ratings changes and target prices for several companies making headlines.
StoneCo Ltd. (NASDAQ:STNE)
StoneCo Ltd. (NASDAQ:STNE) has garnered a "Moderate Buy" consensus from nine brokerages, according to Marketbeat Ratings. While one analyst recommends selling, two suggest holding, and five advise buying.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) also boasts a "Moderate Buy" rating, this time from a larger pool of twenty-five brokerages tracked by MarketBeat Ratings. The breakdown includes one "sell," six "hold," and sixteen "buy" ratings. This suggests strong confidence in the pharmaceutical giant's future performance.
Halozyme Therapeutics, Inc. (NASDAQ:HALO)
Halozyme Therapeutics, Inc. (NASDAQ:HALO) has received a "Moderate Buy" rating from ten analysts, as reported by MarketBeat.com. Four analysts recommend holding the stock, while six are advising a buy. The average twelve-month price target among brokers is $62.78.
J.B. Hunt Transport Services, Inc. (NASDAQ:JBHT)
Shares of J.B. Hunt Transport Services, Inc. (NASDAQ:JBHT) also received a "Moderate Buy" from eighteen analysts, according to Marketbeat Ratings. Five analysts suggest holding the stock, while thirteen recommend buying. The average target price is $191.11.
MannKind (NASDAQ:MNKD)
MannKind (NASDAQ:MNKD) received a boost this week, with StockNews.com upgrading the stock from a "hold" to a "buy" rating. In addition, Wells Fargo & Company initiated coverage on MannKind with an "overweight" rating in a research note issued on Friday, December 20th.
Eagle Financial Services (NASDAQ:EFSI)
DA Davidson initiated coverage on Eagle Financial Services (NASDAQ:EFSI), assigning a "buy" rating and a $40.00 price target, as reported by Benzinga. This target price suggests a potential upside of 23.11% from the stock's current price.
Disclaimer: Analyst ratings are just one factor to consider when making investment decisions. Investors should conduct their own research and consult with a financial advisor before investing in any security.